(03-02) 04:00 PST Washington -- Federal drug regulators have started a broad review of the safety of popular cough and cold remedies meant for children, a top official said Thursday. Dr. Charles Ganley, director of the office of nonprescription drug products at the Food and Drug Administration, said the agency was “revisiting the risks and benefits of the use of these drugs in children” and that “we’re particularly concerned about the use of these drugs in children less than 2 years of age.” >>> Discuss This Story
